Subtopic Deep Dive
Glycosylation Engineering in Recombinant Proteins
Research Guide
What is Glycosylation Engineering in Recombinant Proteins?
Glycosylation engineering in recombinant proteins modifies glycan structures on proteins expressed in insect and mammalian cells to mimic human glycosylation patterns for improved therapeutic efficacy.
This subtopic focuses on using baculovirus vectors in insect cells and mammalian systems to control N-glycan heterogeneity, sialylation, and protein half-life. Key papers include Kost et al. (2005) with 989 citations on baculovirus expression and Aricescu et al. (2006) with 785 citations on mammalian cell production. Over 10 listed papers address expression hosts and bioprocessing.
Why It Matters
Human-like glycosylation enhances recombinant protein stability, reduces immunogenicity, and boosts half-life for therapeutics like antibodies and insulin. Kost et al. (2005) enabled insect cell platforms for viral protein studies, while Tripathi and Shrivastava (2019) detailed process development for infectious disease treatments. Kunert and Reinhart (2016) advanced antibody manufacturing with glycoengineering, impacting biopharmaceutical production for millions.
Key Research Challenges
Insect Cell Glycan Heterogeneity
Insect cells produce high-mannose glycans unlike human complex types, causing immunogenicity. Kost et al. (2005) highlight baculovirus systems but note glycan control needs. Engineering requires targeted modifications for sialylation.
Sialylation in Mammalian Hosts
Mammalian cells like those in Aricescu et al. (2006) offer better glycosylation but face sialic acid inconsistencies affecting protein function. Scale-up challenges persist per Tripathi and Shrivastava (2019). Process optimization demands precise control.
Immunogenicity Reduction Strategies
Recombinant proteins trigger immune responses without proper glycans, as in Frenzel et al. (2013) antibody expression. Glycoengineering targets N-glycans for safety. Balancing yield and quality remains difficult.
Essential Papers
Baculovirus as versatile vectors for protein expression in insect and mammalian cells
Thomas A. Kost, J. Patrick Condreay, Donald L. Jarvis · 2005 · Nature Biotechnology · 989 citations
A time- and cost-efficient system for high-level protein production in mammalian cells
A.R. Aricescu, Weixian Lu, E. Yvonne Jones · 2006 · Acta Crystallographica Section D Biological Crystallography · 785 citations
Most proteins for structural biology studies are produced by high-level expression in Escherichia coli. However, prokaryotic based expression systems fail to generate correctly folded functional fo...
Recent Developments in Bioprocessing of Recombinant Proteins: Expression Hosts and Process Development
Nagesh K. Tripathi, Ambuj Shrivastava · 2019 · Frontiers in Bioengineering and Biotechnology · 531 citations
Infectious diseases, along with cancers, are among the main causes of death among humans worldwide. The production of therapeutic proteins for treating diseases at large scale for millions of indiv...
Biopharmaceutical benchmarks 2022
Gary Walsh, Eithne Walsh · 2022 · Nature Biotechnology · 441 citations
Advances in recombinant antibody manufacturing
Renate Kunert, David Reinhart · 2016 · Applied Microbiology and Biotechnology · 409 citations
Cell factories for insulin production
Nabih A. Baeshen, Mohammed N. Baeshen, Abdullah Sheikh et al. · 2014 · Microbial Cell Factories · 340 citations
The rapid increase in the number of diabetic patients globally and exploration of alternate insulin delivery methods such as inhalation or oral route that rely on higher doses, is bound to escalate...
Progress in biopharmaceutical development
Małgorzata Kęsik-Brodacka · 2017 · Biotechnology and Applied Biochemistry · 335 citations
Abstract Since its introduction in 1982, biopharmaceutical drugs have revolutionized the treatment of a broad spectrum of diseases and are increasingly used in nearly all branches of medicine. In r...
Reading Guide
Foundational Papers
Start with Kost et al. (2005, 989 citations) for baculovirus in insect cells, then Aricescu et al. (2006, 785 citations) for mammalian systems, as they establish core expression platforms.
Recent Advances
Study Tripathi and Shrivastava (2019, 531 citations) for bioprocessing and Kunert and Reinhart (2016, 409 citations) for antibody advances.
Core Methods
Core techniques include baculovirus vectors (Kost et al., 2005), glycoengineering in mammalian cells (Aricescu et al., 2006), and process optimization (Tripathi and Shrivastava, 2019).
How PapersFlow Helps You Research Glycosylation Engineering in Recombinant Proteins
Discover & Search
Research Agent uses searchPapers and citationGraph on 'baculovirus glycosylation engineering' to map Kost et al. (2005, 989 citations) connections, then findSimilarPapers reveals Tripathi and Shrivastava (2019) bioprocessing advances.
Analyze & Verify
Analysis Agent applies readPaperContent to Kost et al. (2005), verifies glycan claims with CoVe against Aricescu et al. (2006), and runs PythonAnalysis on glycan heterogeneity data using pandas for statistical validation with GRADE scoring.
Synthesize & Write
Synthesis Agent detects gaps in sialylation control across Frenzel et al. (2013) and Kunert et al. (2016), flags contradictions; Writing Agent uses latexEditText, latexSyncCitations for Kost et al., and latexCompile for reports with exportMermaid glycan pathway diagrams.
Use Cases
"Analyze glycan profiles from baculovirus insect cell papers using Python"
Research Agent → searchPapers('baculovirus glycosylation') → Analysis Agent → readPaperContent(Kost 2005) → runPythonAnalysis(pandas glycan data plot) → matplotlib output of N-glycan distributions.
"Write LaTeX review on glycosylation engineering in recombinant antibodies"
Synthesis Agent → gap detection(Frenzel 2013, Kunert 2016) → Writing Agent → latexEditText(draft) → latexSyncCitations → latexCompile → PDF with glycoengineered antibody figures.
"Find GitHub code for mammalian cell glycosylation simulation"
Research Agent → exaSearch('glycosylation simulation code') → Code Discovery → paperExtractUrls(Aricescu 2006) → paperFindGithubRepo → githubRepoInspect → verified simulation scripts.
Automated Workflows
Deep Research workflow scans 50+ papers via searchPapers on insect glycosylation, structures report with citationGraph from Kost et al. (2005). DeepScan applies 7-step CoVe analysis to Tripathi (2019) processes with runPythonAnalysis checkpoints. Theorizer generates hypotheses on glycan engineering from Frenzel et al. (2013) antibody data.
Frequently Asked Questions
What is glycosylation engineering in recombinant proteins?
It modifies glycan structures on proteins from insect or mammalian cells to match human patterns, improving function and reducing immunogenicity.
What methods control glycosylation in insect cells?
Baculovirus vectors enable expression with glycoengineering, as in Kost et al. (2005); strategies target N-glycans and sialylation.
What are key papers on this subtopic?
Kost et al. (2005, 989 citations) on baculovirus; Aricescu et al. (2006, 785 citations) on mammalian production; Tripathi and Shrivastava (2019, 531 citations) on bioprocessing.
What open problems exist?
Achieving uniform sialylation at scale and minimizing glycan heterogeneity in high-yield systems, per challenges in Kunert and Reinhart (2016).
Research Viral Infectious Diseases and Gene Expression in Insects with AI
PapersFlow provides specialized AI tools for Biochemistry, Genetics and Molecular Biology researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Glycosylation Engineering in Recombinant Proteins with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Biochemistry, Genetics and Molecular Biology researchers